"It was impressive to see that every dose of retatrutide resulted in clinically meaningful weight reduction for nearly all participants and people with severe obesity on the highest dose lost on average 30% of their body weight during two years." Importantly, treatment with retatrutide not only resulted in robust weight reduction, but also in clear improvements in assessed cardiometabolic health measures
2025;48(3):e25-e27
Other conditions associated with low glutathione include asthma, cancer, lyme disease, rheumatoid arthritis, neurodegenerative diseases, acquired immune deficiency syndrome (AIDS), aging, cystic fibrosis, liver and heart disease, ischemia, stroke, seizure, sickle cell anemia and metabolic diseases such as diabetes and obesity
Bussell, MD, from the University of Chicago described for the Mayo Clinic Proceedings , around half of patients fail to take their medications as prescribed, and there are many reasons why they don't